Women living together have a higher frequency of menstrual migraine

December 10, 2016

Many women are more likely to have migraines around the time of their menstrual period and in some, those migraines can be more severe. Previous studies have determined that women living together often synchronized their menstrual periods. A group of Brazilian researchers decided to compare the frequency of menstrual migraines in women who live together and those who live alone. The results were just published in the journal Headache.

The study looked at female students at a university between the ages of 18 and 30 years, all of whom suffered from migraines. One group of women lived together with two or more other students and the second group lived alone. They were asked to keep a headache diary for three months. The researchers recorded the frequency of headaches, presence of menstrual migraine, intensity of headaches, medications used including contraceptives, and triggering factors such as diet, sleep deprivation, and stress. Half of the women living together had menstrual migraines compared with 17% of women living alone. This finding was not related to the use of a contraceptive, test stress, or sleep deprivation. Women living together also tended to have menstrual cycle at the same time as their roommates.

It was a small study – it had 18 women in each group, so the results are not highly reliable.

Written by
Alexander Mauskop, MD
Continue reading
August 8, 2026
Sugar is bad for your brain, even before you are born.
Sugar consumed in the first two years of life increases the risk of dementia.
Read article
August 6, 2026
Research
An Old Medicine that Could Make Brain Stimulation Work Better for Depression and Other Neurological Conditions
A 2022 clinical trial from the University of Calgary found that adding low‑dose D‑cycloserine (DCS), a partial NMDA‑receptor agonist, to intermittent theta‑burst stimulation (iTBS) significantly increased response and remission rates in depression without serious side effects. Early follow‑up data suggest that timing, dose, and drug levels matter, and raise the possibility that this DCS‑TMS approach could eventually be applied to other neurological conditions—such as migraine, postconcussion syndrome, brain fog, and long COVID
Read article
Insights from Dr. Alexander Mauskop on headaches and migraines
Subscribe to the Blog.
Subscribe
Subscribe